Virologic outcomes with tenofovir-lamivudine-dolutegravir in adults failing PI-based second-line ART

Background: In South African antiretroviral guidelines, selected patients failing second-line protease inhibitor (PI)-based therapy qualify for genotypic resistance testing – those with PI resistance receive darunavir-based third-line regimens; those without PI resistance continue current regimen wi...

Полное описание

Библиографические подробности

Главные авторы:	Ying Zhao, Jacqueline Voget, Isaac Singini, Zaayid Omar, Vanessa Mudaly, Andrew Boulle, Gary Maartens, Graeme Meintjes
Формат:	Artigo
Язык:	Inglês
Опубликовано:	AOSIS 2024-04-01
Серии:	Southern African Journal of HIV Medicine
Предметы:	antiretroviral therapy dolutegravir hiv virologic failure third-line.
Online-ссылка:	https://sajhivmed.org.za/index.php/hivmed/article/view/1567
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!